CMS seeks proposals for imaging demo: The agency is taking applications through Sept. 21 from groups who want to participate in its two-year Medicare Imaging Demonstration to test whether decision-support systems can improve quality of care and reduce unnecessary radiation exposure. The project will study the use of clinical guidelines to judge the appropriateness of 11 advanced imaging procedures involving magnetic resonance imaging, computed tomography and nuclear medicine imaging. The Medicare Improvements for Patients and Providers Act of 2008 prohibits the use of prior authorization in the demonstration (1"The Gray Sheet" Jan. 4, 2010). CMS wants 2,500 to 3,500 physicians from 500 to 650 physician practices - varied by size, specialty mix and location - to participate. The agency will use participating conveners, such as physician groups, health plans, radiology benefit managers or medical specialty societies, to help recruit physicians for the test
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.
Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
